MoleMapCD Technology

Saving people from melanoma
one patient at a time

Our Mission Statement

A Message from our CEO

My vision for DigitalDerm, Inc., is to live out our company's mission statement:

To develop and deliver to healthcare professionals the best service available and to make the life of those individuals who use our service as uncomplicated and user-friendly as possible.

If we succeed, DigitalDerm will enable physicians to improve early detection of melanoma for at-risk patients through the adoption of the MoleMapCD System as a standard of care. As such, we will provide the most technologically advanced Total Body Photography imaging system available.

The DigitalDerm of the future will be larger and more complex than the company of today. However, we will strive to maintain our close relationships with the healthcare professionals and patients who use our services. As we grow, our commitment to quality of service will never waver.

The members of our DigitalDerm family are passionate about their work. They view this work as an opportunity to serve our clients and for personal development and fulfillment. They are unique individuals with dignity and intrinsic value, independent of the work they do. Their combined efforts will provide the unique service called MoleMapCD.

The quest is not for profits, but to provide the best quality MoleMapCD service. This objective will be accomplished because of the efforts and quality of our people. Their contributions will generate a high-quality service and corporate profits, while providing a beneficial service to patients who are at-risk for melanoma.

Martin Lefkowitz
CEO, DigitalDerm, Inc.

DigitalDerm, Inc., is committed to the needs of the medical community and to those they serve. Our mission is:

To develop and deliver to healthcare professionals the best service available and to make the life of those individuals who use our service as uncomplicated and user-friendly as possible.

DigitalDerm, Inc., will establish the MoleMapCD System as a standard of care for early detection of melanoma by educating physicians as to its benefits and applications, and by supporting physicians and patients in integrating the MoleMapCD System into their daily practices.

We pledge to continue to upgrade and further develop the MoleMapCD by incorporating the latest available technology; listening to the healthcare professionals who prescribe our service; and by focusing on the needs of those who use our service.

We will work together on the process of filling these needs through cooperation, effort and creativity. We will form strong relationships with the healthcare professionals and patients with whom we work. In addition, we will judge behavior in every phase of our business by how it helps us to better serve our patients.

As we strive to live our mission every day, we will grow and prosper as a company, and in the process become better human beings.

Home | Patient | Physician | FAQ | About Us | Melanoma Links | Careers | Disclaimer | Privacy | Contact Us
© DigitalDerm™, Inc. All rights reserved
MoleMapCD© is a registered trademark of DigitalDerm™, Inc.